INTERLEUKIN-33 IS EXPRESSED IN HUMAN ATHEROSCLEROTIC TISSUE AND INCREASES PRO-INFLAMMATORY MEDIATORS IN HUMAN ENDOTHELIAL CELLS BUT NOT IN SMOOTH MUSCLE AND CARDIAC CELLS.

Svitlana Demyanets(Medical University of Vienna), Johann Wojta(Medical University of Vienna), Stefan Pfaffenberger(Medical University of Vienna), Kathrin Rychli(University of Veterinary Medicine Vienna), Gerald Maurer(European Society of Radiology), Kurt Huber(Sigmund Freud Privatuniversität Wien), Christoph Kaun(University of Vienna), I. Huk(Medical University of Vienna)
Journal of the American College of Cardiology
March 1, 2010
10.1016/s0735-1097(10)61535-5
Cited by 0

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation
|Circulation|2011|1.1k
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2011|877
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755